Regen BioPharma (RGBP) Stock Chart & Stock Price History 0.15 +0.04 (+30.56%) (As of 11/4/2024 09:08 PM ET) Add Compare Share Share Chart Stock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Regen BioPharma Stock Price Performance5 Day Performance-67.22%1 Month Performance-51.02%3 Month Performance-59.21%6 Month Performance-31.45%Year-To-Date Performance-52.38%1 Year Performance-71.18% Receive RGBP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Regen BioPharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. RGBP Stock Chart for Tuesday, November, 5, 2024 RGBP Chart by TradingView Regen BioPharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/04/2024N/A0.150.260.1517,500 shs$0.0011/01/20240.460.23-49.78%0.450.231,300 shs$0.0010/31/20240.460.460.460.273,000 shs$0.0010/30/20240.430.46+6.93%0.460.212,300 shs$0.0010/29/20240.470.43-7.54%0.460.231,502 shs$0.0010/28/2024N/A0.470.510.205,500 shs$0.00 Get the Latest News and Ratings for RGBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Regen BioPharma and its competitors with MarketBeat's FREE daily newsletter. 10/25/20240.300.32+7.02%0.340.221,200 shs$0.0010/24/20240.220.30+35.29%0.370.231,900 shs$0.0010/23/20240.450.22-50.89%0.470.223,300 shs$0.0010/22/20240.470.45-4.26%0.480.302,400 shs$0.0010/21/2024N/A0.470.520.313,000 shs$0.0010/18/20240.310.49+57.71%0.490.261,700 shs$0.0010/17/20240.310.31-0.67%0.500.309,400 shs$0.0010/16/20240.330.31-3.97%0.540.2511,400 shs$0.0010/15/20240.330.330.420.2913,100 shs$0.0010/14/2024N/A0.330.330.229,100 shs$0.0010/11/20240.180.24+33.33%0.500.2464,400 shs$0.0010/10/20240.220.18-17.62%0.180.15600 shs$0.0010/09/20240.320.22-31.72%0.300.163,100 shs$0.0010/08/20240.320.320.330.15800 shs$0.0010/07/2024N/A0.320.330.15800 shs$0.0010/04/20240.320.31-3.57%0.330.1711,600 shs$0.0010/03/2024N/A0.320.330.181,700 shs$0.0010/01/20240.210.28+36.32%0.350.2215,600 shs$0.0009/30/2024N/A0.210.210.21100 shs$0.0009/27/20240.220.20-8.91%0.220.165,700 shs$0.0009/26/20240.170.22+33.19%0.270.176,800 shs$0.0009/25/20240.270.17-38.85%0.170.17800 shs$0.0009/24/20240.300.27-9.43%0.300.212,900 shs$0.0009/23/2024N/A0.300.300.285,200 shs$0.0009/20/20240.130.30+130.69%0.300.1819,400 shs$0.0009/19/20240.150.13-11.86%0.200.132,900 shs$0.0009/18/20240.200.15-25.99%0.150.14400 shs$0.0009/17/20240.250.20-19.54%0.200.201,200 shs$0.0009/16/2024N/A0.250.250.151,100 shs$0.0009/13/20240.180.25+37.76%0.250.151,100 shs$0.0009/12/20240.190.18-5.32%0.200.122,200 shs$0.0009/11/20240.200.19-7.09%0.190.181,600 shs$0.0009/10/20240.250.20-19.02%0.230.20300 shs$0.0009/09/2024N/A0.250.270.123,900 shs$0.00The Final Frontier (Ad)And a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt to discredit it, tar and feather it, and convince you not to watch it. That’s because it tells the shocking truth about the current AI mania… and why investors in big tech companies like Nvidia, Meta, Alphabet, and Microsoft could be in for a whole world of pain.Here’s the full story for you.09/06/20240.270.24-11.75%0.260.172,000 shs$0.0009/05/20240.290.27-8.49%0.270.25543 shs$0.0009/04/20240.330.29-11.74%0.300.186,089 shs$0.0009/03/20240.320.33+3.06%0.330.199,341 shs$0.0009/02/2024N/A0.320.330.202,500 shs$0.0008/30/20240.330.32-3.06%0.330.202,500 shs$0.0008/29/20240.340.33-2.91%0.340.154,200 shs$0.0008/28/20240.160.34+112.17%0.370.168,700 shs$0.0008/27/20240.170.16-5.76%0.300.16900 shs$0.0008/26/2024N/A0.170.290.1712,400 shs$0.0008/23/20240.200.30+49.40%0.300.153,300 shs$0.0008/22/20240.380.20-46.67%0.350.2037,000 shs$0.0008/21/20240.380.38-1.32%0.380.37200 shs$0.0008/20/20240.390.38-1.30%0.390.3010,900 shs$0.0008/19/2024N/A0.390.390.385,800 shs$0.0008/16/20240.380.380.390.383,600 shs$0.0008/15/20240.380.380.380.375,600 shs$0.0008/14/20240.350.38+8.57%0.380.32400 shs$0.0008/13/20240.350.350.390.302,400 shs$0.0008/12/2024N/A0.350.390.302,400 shs$0.0008/09/20240.370.370.380.301,000 shs$0.0008/08/20240.370.370.380.3011,800 shs$0.0008/07/20240.300.37+23.33%0.380.303,800 shs$0.0008/06/20240.370.30-18.85%0.390.3015,700 shs$0.0008/05/2024N/A0.370.370.2826,400 shs$0.00 Related Companies 180 Life Sciences Stock Chart 4D pharma Stock Chart 4Front Ventures Stock Chart Abattis Bioceuticals Stock Chart Aeolus Pharmaceuticals Stock Chart Aesther Healthcare Acquisition Stock Chart Agentix Stock Chart Ainos Stock Chart Algernon Pharmaceuticals Stock Chart Allstar Health Brands Stock Chart Receive RGBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Regen BioPharma and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:RGBP) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regen BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Regen BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RGBP Stock Alerts